Resources

Past Presentation

Atypical Antipsychotic Agents & Diabetes | August 5, 2021

Date of Presentation: August 5, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #atypical antipsychotics  

Dr. Mary Carol Greenlee, practitioner at Western Slope Endocrinology in Grand Junction, Colorado, discusses caring for patients with diabetes who are prescribed atypical antipsychotics. These medications are associated with weight gain and alterations in glucose metabolism, making management difficult for patients with diabetes. They are also associated with new-onset diabetes, particularly in younger patients. Dr. Greenlee gives an overview of the risk factors, screening recommendations, and management best practices based on emerging clinical studies.

Presented by:

Dr. Mary Carol Greenlee

Mary Carol Greenlee, MD, MACP, is board certified in internal medicine and in endocrinology, diabetes, and metabolism with over 30 years’ experience in private practice. Dr. Greenlee graduated Summa Cum Laude from Miami University (Ohio) and with Highest Distinction from Indiana University School of Medicine. She did her internal medicine internship and residency at Ball Memorial Hospital in Muncie, IN before returning to IU Medical Center for her fellowship in endocrinology. Carol chaired the “AID” project to develop shared decision-making tools for insulin therapy, as well as several workgroups focused on improving care coordination between primary and specialty care. She received NCQA recognition for Patient-Centered Specialty Care in 2014 and the Endocrine Society award for Outstanding Clinical Practitioner in 2016.

Resources Provided:

Date added: September 16, 2021